Contents 1. Executive Summary 2. Ambulatory Surgical Centers Market 2.1. Product Overview 2.2. Market Definition 2.3. Segmentation 2.4. Assumptions and Acronyms 3. Research Methodology 3.1. Research Objectives 3.2. Primary Research 3.3. Secondary Research 3.4. Forecast Model 3.5. Market Size Estimation 4. Average Pricing Analysis 5. Macro-Economic Indicators 6. Market Dynamics 6.1. Growth Drivers 6.2. Restraints 6.3. Opportunity 6.4. Trends 7. Correlation & Regression Analysis 7.1. Correlation Matrix 7.2. Regression Matrix 8. Recent Development, Policies & Regulatory Landscape 9. Risk Analysis 9.1. Demand Risk Analysis 9.2. Supply Risk Analysis 10. Ambulatory Surgical Centers Analysis 10.1. Porters Five Forces 10.1.1. Threat of New Entrants 10.1.2. Bargaining Power of Suppliers 10.1.3. Threat of Substitutes 10.1.4. Rivalry 10.2. PEST Analysis 10.2.1. Political 10.2.2. Economic 10.2.3. Social 10.2.4. Technological 11. Ambulatory Surgical Centers Market 11.1. Market Size & forecast, 2019A-2030F 11.1.1. By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 11.1.2. By Volume (Million Units) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12. Ambulatory Surgical Centers: Market Segmentation 12.1. By Regions 12.1.1. North America: • By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.1.2. Europe: • By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.1.3. Asia-Pacific: • By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.1.4. MEA: • By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.1.5. Latin America: • By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.2. By Component: Market Share (2020-2030F) 12.2.1. Hardware, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.2.2. Software, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.2.3. Services, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.3. By Application: Market Share (2020-2030F) 12.3.1. Ophthalmology, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.3.2. Orthopedics, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.3.3. Gastroenterology, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.3.4. Pain Management/Spinal Injections, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.3.5. Plastic Surgery, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 12.3.6. Others, By Value (USD Million) 2019-2030F; Y-o-Y Growth (%) 2020-2030F 13. Company Profile 13.1.1. United Surgical Partners. 13.1.2. Company Overview 13.1.3. Company Total Revenue (Financials) 13.1.4. Market Potential 13.1.5. Global Presence 13.1.6. Key Performance Indicators 13.1.7. SWOT Analysis 13.1.8. Product Launch 13.2. Surgery Partners 13.3. Surgical Care Affiliates 13.4. Envision Healthcare Holdings 13.5. Mednax 13.6. Team Health Holdings 13.7. Tenet Healthcare 13.8. SurgCenter Development 13.9. Suprabha Surgicare 14 Consultant Recommendation **The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.